This putative negative correlation between the expression of MYC/MYCL/MYCN and HIF2A is supported by data retrieved from the databank of a published expression analysis of 81 SCLC tumor specimens showing that tumors with high pan-MYC expression generally express low levels of HIF2A (Figure 1G; PMID: 26168399). The gene discussed is EPAS1; the disease is neoplasm.